NGS-based RNA-sequencing Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2028 | Illumina, Thermo Fischer Scientific, Oxford Nanopore

"
The NGS-based RNA-sequencing global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors. Readers can enhance their knowledge on the trading strategies, recent developments, current and future progress of the key players in the NGS-based RNA-sequencing global market.

The report includes an in-depth study of the global market segment NGS-based RNA-sequencing, where segments and sub-segments are analyzed in quite detail. This research will help players focus on high growth segments and modify their business strategy, if needed. The NGS-based RNA-sequencing global market is segmented based on type, application and geography. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, China, Europe, India , US, UK and MEA. Our researchers and analysts use reliable primary and secondary sources for research and data.

Major Players : Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics

Request a sample of the report at : https://www.qyresearch.com/sample-form/form/4798341/Global-NGS-based-RNA-sequencing-Market-Research-Report-2022

Global NGS-based RNA-sequencing Market Types: Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing

Global NGS-based RNA-sequencing Market Applications: Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Study Coverage: This section includes brief information about key products sold in the global NGS-based RNA-sequencing market followed by an overview of important segments and manufacturers covered in the report. It also gives highlights of market size growth rates of different type and application segments. Furthermore, it includes information about study objectives and years considered for the complete research study.

Executive Summary: Here, the report focuses on key trends of various products and other markets. It also shares analysis of the competitive landscape, where prominent players and market concentration ratio are shed light upon. Prominent players are studied on the basis of their date of market entry, products, manufacturing base distribution, and headquarters.

Market Size by Manufacturer: In this part of the report, expansion plans, mergers and acquisitions, and price, revenue, and production by manufacturer are analyzed. This section also provides revenue and production shares by manufacturer.

Production by Region: Apart from global production and revenue shares by region, the authors have shared critical information about regional production in different geographical markets. Each regional market is analyzed taking into account vital factors, viz. import and export, key players, and revenue, besides production.

Consumption by Region: The report concentrates on global and regional consumption here. It provides figures related to global consumption by region such as consumption market share. All of the regional markets studied are assessed on the basis of consumption by country and application followed by analysis of country-level markets.

Market Size by Type: It includes analysis of price, revenue, and production by type.

Market Size by Application: It gives an overview of market size analysis by application followed by analysis of consumption market share, consumption, and breakdown data by application.

Key Industry Players: Leading players of the industry are profiled here on the basis of economic activity and plans, SWOT analysis, products, revenue, production, and other company details.

Entry Strategy for Key Countries: Entry strategies for all of the country-level markets studied in the report are provided here.

Production Forecasts: Apart from global production and revenue forecasts, this section provides production and revenue forecasts by region. It also includes forecast of key producers, where important regions and countries are taken into consideration, followed by forecast by type.

Consumption Forecast: It includes global consumption forecast by application and region. In addition, it provides consumption forecast for all regional markets studied in the report.

Opportunities and Challenges, Threats, and Affecting Factors: It includes Porter's Five Forces analysis, market challenges, opportunities, and other market dynamics.

Key Findings of the Study: These give a clear picture of the current and future status of the global NGS-based RNA-sequencing market.

Request for customization in Report: https://www.qyresearch.com/customize-request/form/4798341/Global-NGS-based-RNA-sequencing-Market-Research-Report-2022

Table of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2017-2028)
2.2 NGS-based RNA-sequencing Growth Trends by Region
2.2.1 NGS-based RNA-sequencing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2017-2022)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2023-2028)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2017-2022)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2017-2022)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2021
3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
3.7 Date of Enter into NGS-based RNA-sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2017-2022)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2023-2028)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2017-2022)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2017-2028)
6.2 North America NGS-based RNA-sequencing Market Size by Country (2017-2022)
6.3 North America NGS-based RNA-sequencing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2017-2028)
7.2 Europe NGS-based RNA-sequencing Market Size by Country (2017-2022)
7.3 Europe NGS-based RNA-sequencing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2017-2028)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Country (2017-2022)
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2017-2028)
9.2 Latin America NGS-based RNA-sequencing Market Size by Country (2017-2022)
9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2017-2028)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2017-2022)
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Detail
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Detail
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Detail
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Detail
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Detail
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Detail
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Detail
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2017-2022)
11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Contact Us:
QY Research, INC.
17890 Castleton, Suite 369,
Los Angeles, CA - 91748
USA: +1 626 539 9760
India: +91 9766 478 224
Emails - enquiry@qyresearch.com
Web - www.qyresearch.com

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US:

QY RESEARCH, INC.

17890 CASTLETON STREET

SUITE 369, CITY OF INDUSTRY

CA - 91748, UNITED STATES OF AMERICA

+1 626 539 9760 / +91 8669986909

hitesh@qyresearch.com / enquiry@qyresearch.com"

This release was published on openPR.